Musings from The Power List: Ansgar Korf - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Musings from The Power List: Ansgar Korf

  • October 9, 2026

  • 7 min

Share

Clinical Scorecard: Musings from The Power List: Ansgar Korf

At a Glance

CategoryDetail
ConditionNot applicable; the source discusses analytical science and untargeted small-molecule mass spectrometry, not a medical condition.
Key MechanismsMZmine develops computational methods and open infrastructure to process untargeted small-molecule mass spectrometry data into structured, reusable data. The interviewee identifies matrix effects, ion suppression, batch drift, and storage-related degradation as systematic errors that models may learn as signal.
Target PopulationResearchers working with untargeted small-molecule mass spectrometry data.
Care SettingAnalytical science research and laboratory data processing; no patient-care setting is discussed.

Key Highlights

  • The interviewee says the MZmine team develops computational methods and open infrastructure to address data-processing bottlenecks in untargeted mass spectrometry.
  • FAIR-MS is described as applying MZmine processing capabilities to make mass spectrometry data findable and reusable at the scale needed for machine learning.
  • Untargeted datasets can be revisited years later to address questions that were not anticipated when data were acquired.
  • The interviewee says targeted methods remain essential wherever a validated answer is required.
  • The interviewee says study design, sampling, sample preparation, acquisition, and processing each constrain what the other workflow stages can achieve.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Not applicable; the article concerns analytical science and mass spectrometry research, not patient care.

          No treatments or prescribing information are discussed.

          Clinical Best Practices

          • Consider study design, sampling, sample preparation, acquisition, and processing as interdependent parts of the analytical workflow.
          • Address systematic sources of error across the workflow; the source cautions that scale alone does not remedy systematic error.
          • Make mass spectrometry data comparable and reusable to support large-scale machine-learning applications.

          Related Resources & Content

          Original Source(s)

          Related Content